[Immunotherapy with BCG in pulmonary tumors].
Results obtained with immunotherapy in 318 cases of lung cancer showed that an initial Tine test is useful prognostically (initial negativity is equivalent to poor survival), and survival increases and decreases in function of positivity and negativity respectively. The soundness of immunotherapy is borne out by the survival data.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D014374:Tuberculin Test
D000970:Antineoplastic Agents; D001500:BCG Vaccine
Immunoterapia con BCG nei tumori polmonari